Radiofrequency ablation for hepatic hemangiomas: A consensus from a Chinese panel of experts

World J Gastroenterol. 2017 Oct 21;23(39):7077-7086. doi: 10.3748/wjg.v23.i39.7077.

Abstract

Recent studies have shown that radiofrequency (RF) ablation therapy is a safe, feasible, and effective procedure for hepatic hemangiomas, even huge hepatic hemangiomas. RF ablation has the following advantages in the treatment of hepatic hemangiomas: minimal invasiveness, definite efficacy, high safety, fast recovery, relatively simple operation, and wide applicability. It is necessary to formulate a widely accepted consensus among the experts in China who have extensive expertise and experience in the treatment of hepatic hemangiomas using RF ablation, which is important to standardize the application of RF ablation for the management of hepatic hemangiomas, regarding the selection of patients with suitable indications to receive RF ablation treatment, the technical details of the techniques, therapeutic effect evaluations, management of complications, etc. A final consensus by a Chinese panel of experts who have the expertise of using RF ablation to treat hepatic hemangiomas was reached by means of literature review, comprehensive discussion, and draft approval.

Keywords: Consensus; Hepatic hemangiomas; Radiofrequency ablation.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Catheter Ablation* / adverse effects
  • Catheter Ablation* / mortality
  • China
  • Consensus
  • Hemangioma / mortality
  • Hemangioma / pathology
  • Hemangioma / surgery*
  • Humans
  • Liver Neoplasms / mortality
  • Liver Neoplasms / pathology
  • Liver Neoplasms / surgery*
  • Postoperative Complications / etiology
  • Risk Factors
  • Treatment Outcome